|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.04 EUR | +0.29% |
|
-1.26% | -19.24% |
| 05-11 | DANONE : Barclays gives a Buy rating | ZD |
| 05-05 | Weight-loss drugs fuel protein-rich whey craving | RE |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 32.03B | 6.69% | 13.43% | 14.18% | 5.45% | 1.68x | ||
| 113B | 10.09% | 16.08% | 33.1% | 8.54% | 2.85x | ||
| 38.54B | 6.36% | 13.17% | 9.29% | 3.5% | 2.97x | ||
| 80.27B | 1.34% | 1.77% | 4.8% | 4.7% | 2.02x | ||
| 11.69B | 7.55% | 16.85% | 27.45% | 9.62% | 1.81x | ||
| 10.22B | 4.59% | 7.45% | 9% | 6.2% | 1.18x | ||
| 2.36B | 16.41% | 20.96% | 88.88% | 29.01% | 0.22x | ||
| 24.94B | -23.44% | 19.02% | 6.78% | 3.62% | 3.26x | ||
| 70.33B | 1.16% | 2.89% | 8.9% | 3.63% | 4.72x | ||
| 35.05B | 1.29% | 2.14% | 3.32% | 1.39% | 4.5x | ||
| 70.42B | 2% | 3.4% | 6.8% | 2.25% | 6.54x | ||
| 19.49B | 11.78% | 17.2% | 25.22% | 7.27% | 3.73x | ||
| 26.37B | 5.27% | 8.91% | 9.22% | 5.35% | 0.98x | ||
| 21.43B | 2.92% | 5.18% | 14.49% | 2.71% | 2.18x | ||
| 7.93B | 9.75% | 13.31% | 10.59% | 5.68% | 1.86x | ||
| 1.25B | - | 31.34% | - | - | - | ||
| 6.84B | 11.54% | 15.99% | 14.64% | 6.14% | 2.94x | ||
| 13.26B | -0.92% | 4.91% | 8.83% | 4.39% | 2.13x | ||
| 5.88B | 11.13% | 14.03% | 12.49% | 6.5% | 2.24x | ||
| 1.27B | 15.04% | 18.11% | 41.73% | 20.67% | -0.75x | ||
| Average | 29.62B | 5.29% | 12.31% | 18.41% | 7.19% | 2.48x | |
| Weighted average by Cap. | 58.76B | 6.51% | 13.3% | 22.74% | 7.41% | 2.60x |
- Stock Market
- Equities
- BN Stock
- Sector Danone
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















